Rate and amplification of drug resistance among previously-treated patients with tuberculosis in Kampala, Uganda - Test2 - elhamkhani - TriplyDB

Rate and amplification of drug resistance among previously-treated patients with tuberculosis in Kampala, Uganda

Rate and amplification of drug resistance among previously-treated patients with tuberculosis in Kampala, Uganda

http://www.wikidata.org/entity/Q33904830

about

Risk Factors for Acquired Rifamycin and Isoniazid Resistance: A Systematic Review and Meta-Analysis Multidrug-Resistant Tuberculosis in Patients with Chronic Obstructive Pulmonary Disease in China Rates of anti-tuberculosis drug resistance in Kampala-Uganda are low and not associated with HIV infection Effectiveness of the standard WHO recommended retreatment regimen (category II) for tuberculosis in Kampala, Uganda: a prospective cohort study High prevalence of primary multidrug resistant tuberculosis in persons with no known risk factors Rifampicin for continuation phase tuberculosis treatment in Uganda: a cost-effectiveness analysis Aetiology of pulmonary symptoms in HIV-infected smear negative recurrent PTB suspects in Kampala, Uganda: a cross-sectional study Elucidating emergence and transmission of multidrug-resistant tuberculosis in treatment experienced patients by whole genome sequencing Association between Mycobacterium tuberculosis complex phylogenetic lineage and acquired drug resistance Association between HIV/AIDS and multi-drug resistance tuberculosis: a systematic review and meta-analysis The Relationship between Extensively Drug-Resistant Tuberculosis and Multidrug-Resistant Gram-Negative Bacilli The Role of Adherence and Retreatment in De Novo Emergence of MDR-TB Comparison of rapid tests for detection of rifampicin-resistant Mycobacterium tuberculosis in Kampala, Uganda.Determinants of multidrug-resistant tuberculosis in patients who underwent first-line treatment in Addis Ababa: a case control study.Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology Use of the GenoType(R) MTBDRplus assay to assess drug resistance of Mycobacterium tuberculosis isolates from patients in rural Uganda Risk factors for tuberculosis treatment failure, default, or relapse and outcomes of retreatment in Morocco Tuberculosis in Sudan: a study of Mycobacterium tuberculosis strain genotype and susceptibility to anti-tuberculosis drugs.Emergence of increased resistance and extensively drug-resistant tuberculosis despite treatment adherence, South Africa High Frequency of First-Line Anti-Tuberculosis Drug Resistance among Persons with Chronic Pulmonary Tuberculosis at a Teaching Hospital Chest Clinic.Characteristics of multidrug-resistant tuberculosis in Namibia.Utility of the REBA MTB-Rifa® assay for rapid detection of rifampicin resistant Mycobacterium tuberculosis."Home is where the patient is": a qualitative analysis of a patient-centred model of care for multi-drug resistant tuberculosis.High mortality associated with retreatment of tuberculosis in a clinic in Kampala, Uganda: a retrospective study.Acquired Drug Resistance in Mycobacterium tuberculosis and Poor Outcomes among Patients with Multidrug-Resistant Tuberculosis.Drug resistance patterns of Mycobacterium tuberculosis complex and associated factors among retreatment cases around Jimma, Southwest Ethiopia.Tuberculosis retreatment 'others' in comparison with classical retreatment cases; a retrospective cohort review.First national survey of anti-tuberculosis drug resistance in Azerbaijan and risk factors analysis.Prevalence of positive tuberculin skin test and associated factors among Makerere medical students, Kampala, Uganda.Epidemiological Trends of Drug-Resistant Tuberculosis in China From 2007 to 2014: A Retrospective Study.Genotypic Detection of rpoB and katG Gene Mutations Associated with Rifampicin and Isoniazid Resistance in Mycobacterium Tuberculosis Isolates: A Local Scenario (Kelantan).Epidemiology and genetic diversity of multidrug-resistant tuberculosis in East Africa.The emergence of extensively drug-resistant tuberculosis: a global health crisis requiring new interventions: part I: the origins and nature of the problem.Molecular detection of multidrug-resistant tuberculosis among smear-positive pulmonary tuberculosis patients in Jigjiga town, Ethiopia.The emergence of extensively drug-resistant tuberculosis: a global health crisis requiring new interventions: Part II: scientific advances that may provide solutions Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities.

P2860

Q26781111-73520EB4-DD39-4137-9FFA-1B1129E0D4EB Q28386082-3CFAF092-F216-4F6E-A407-E6A05F5BB3DD Q28476713-16422B18-D11A-4F32-AE16-BB93C37799B1 Q28477435-4801ED4E-53B3-4996-968B-BD32F9DFF54D Q28477658-38D2AD93-506E-49D3-9C56-5913A8945E8F Q28480467-B133AD30-C063-427F-BD9A-98175C75C205 Q28535816-5423FC54-CB13-411B-A997-A7F9C52F75C4 Q28536869-92FA266E-33EC-4489-8DAB-2B0108EF6558 Q28537951-D5002BE8-3529-4164-AC38-7E20CCFD2928 Q28538427-4B46C8BF-4595-4FC6-877B-DCB08D974285 Q28546927-9AA86AED-66E0-4B66-9437-2D0D2AE617BA Q28550707-717A03D0-BB6A-466F-B190-3F1AAC161FD4 Q33497027-6CF15A7C-F5AA-4114-A754-A9DF455181FE Q33586629-6E197B96-6EE4-4254-A838-C9B67B21EC20 Q33614228-3FEA7CDA-1FAC-48E8-AB19-CD9641A1B248 Q33651616-ABA404A5-DE7E-493F-839F-D84732E74D3C Q33830959-8F2C1575-1409-4D70-A1C6-2A7953219150 Q33994134-ACD07556-B848-4848-92EA-DDB39B95458D Q34216252-1DA20A76-084E-45FC-B387-359095376BC0 Q34363124-253565F3-9F81-448D-A747-AD380E43188E Q34526722-DE3641E8-0342-4911-A5E7-FBF6FA01E3D0 Q35017694-A45CA46D-FCA6-4BAE-92CB-F91A9DF8A1AB Q35100096-64A4B5FE-2EC2-4D6E-99B4-745E560B2DBB Q35621974-1B018C99-1337-46D9-A3BF-1B5964700AE4 Q35673445-03290F57-B8CC-4E44-9E10-E7DD8294BFCA Q35681236-226E0A5C-EBF3-43BF-B19C-3E65221673F9 Q35761800-60911A99-A0B6-4FA5-8FD0-9A7AF62E4530 Q35990621-CD7994F7-0DB5-4754-B32F-38CBA7B80D2B Q36612565-4A1AF667-3E91-4F26-99BF-546D55DF7827 Q36822433-3C5DE52D-4A04-4045-AFFF-D9909FD80667 Q37155860-8040D180-057D-4DD1-92F7-29F500FE2F57 Q37423406-DF54F6A5-F1E7-441B-934C-7EDA6ADC614E Q37700331-44464E4E-B53D-4712-86F5-AB03F2BAFEB1 Q37702443-7882C323-E25E-48CE-92C5-DFB55ED8BE2E Q37742687-5CE12E7E-E070-4891-B00E-A4BF70E30E41 Q38002002-47C00790-8EA5-422F-9FF6-EE24AC1BECD4

P2860

Rate and amplification of drug resistance among previously-treated patients with tuberculosis in Kampala, Uganda

http://www.wikidata.org/entity/Q33904830

description

2008 nî lūn-bûn

@nan

2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Rate and amplification of drug ...... uberculosis in Kampala, Uganda

@ast

Rate and amplification of drug ...... uberculosis in Kampala, Uganda

@en

type

label

Rate and amplification of drug ...... uberculosis in Kampala, Uganda

@ast

Rate and amplification of drug ...... uberculosis in Kampala, Uganda

@en

prefLabel

Rate and amplification of drug ...... uberculosis in Kampala, Uganda

@ast

Rate and amplification of drug ...... uberculosis in Kampala, Uganda

@en

P1433

Q33904830-91DE7716-1707-4901-8FBA-B8CD70D6C7AF

P1476

Q33904830-6D991FC0-FE88-4A9E-872D-96596E41AC0F

P2093

Q33904830-0A61A83A-9010-4927-92F0-DCA9A0FD5C2E

Q33904830-2B28826D-E6AB-4B59-BEBC-4BAE1AEE2DE0

Q33904830-38137387-3938-40E4-8A68-BC3ACC541A07

Q33904830-51CAD99F-24D5-49CB-BFAB-6B5ADDD3A5B8

Q33904830-528F1423-52FF-41F6-B8F6-1CCC633B13A9

Q33904830-AE46B8C3-C804-4869-823C-A04ED3793416

Q33904830-B11D5E99-AB4E-4271-AF6F-E25DABE2B4A2

Q33904830-B223CF4D-424F-469B-9796-8161390466D9

Q33904830-BF0B6232-39C2-4233-A4D8-7A07A9D09C65

Q33904830-C664E6E7-1D07-4E5D-BCF6-599829E0A1EB

P2860

Q33904830-0331099D-BCAC-48B2-A2CA-9DB15A6FC590

Q33904830-1817EC5E-5923-40C5-94DA-3D8A6BAAAB2C

Q33904830-1E1B0619-58AF-45BA-AE97-BF3F23D9C301

Q33904830-2149CDB7-4979-41D4-98C8-DD59C8A35B40

Q33904830-27533DDA-49B8-40DD-BF25-301004F95E18

Q33904830-2E59678A-ADA1-42CE-8B2C-D8C3A9B4D368

Q33904830-33744DCA-E9C0-4AF6-81BD-DCF5FBC17F1B

Q33904830-339FCFC8-FA1F-47A2-B3C7-AB95307C7F5C

Q33904830-3FB47BBB-BB7B-41A6-8EE8-9CD6D1B8057F

Q33904830-4C4D7710-1A38-48F6-B514-76F2CF64074E

P304

Q33904830-15F0578A-61E3-42AD-B7CB-C4819841C6D2

P31

Q33904830-7E17EA84-1CB9-4FEB-8CBD-C3AC5335950C

P356

Q33904830-A40F164F-E806-49B0-B982-F84BB5188678

P407

Q33904830-FA336404-BAED-4289-8EF8-9A20ACBFCEFA

P433

Q33904830-85590087-D85E-4576-A4D8-A8C1BDEC806B

P478

Q33904830-568A9AEF-75E3-4571-8273-BC249530DC96

P50

Q33904830-1E1BD3D0-041D-4FC3-B371-DC5BC9031499

Q33904830-414907B0-7581-47AA-A2C8-DDE16E8E0725

Q33904830-53CB0893-3EC7-4650-942A-173C9798531F

Q33904830-5AA08FB2-2214-45CD-89C9-5A58815219F7

Q33904830-71CBE8BB-C11C-409B-BA28-777D0DF2AE34

Q33904830-A7C78D9F-7250-4F0E-ADD0-24B236507BB1

P577

Q33904830-3577CE1A-625B-4B38-B92C-AECC26662765

P5875

Q33904830-4B129747-44E0-4835-8A08-555B5D4E2935

P698

Q33904830-85180ED4-844C-4FCD-9F81-A26E34A857C1

P921

Q33904830-563D7C8D-1B94-461A-9F53-F06F55F30A27

Q33904830-970FB500-8671-4DC5-9588-5301CA3012BE

P932

Q33904830-233EC406-D88F-413A-BFB7-558E7E2234D6

P356

P1433

Clinical Infectious Diseases

P1476

Rate and amplification of drug ...... uberculosis in Kampala, Uganda

@en

P2093

Alphonse Okwera

http://www.w3.org/2001/XMLSchema#string

Beth Temple

http://www.w3.org/2001/XMLSchema#string

Helen Nabanjja

http://www.w3.org/2001/XMLSchema#string

Irene Ayakaka

http://www.w3.org/2001/XMLSchema#string

Jonathan Levin

http://www.w3.org/2001/XMLSchema#string

Kathleen D Eisenach

http://www.w3.org/2001/XMLSchema#string

Roy D Mugerwa

http://www.w3.org/2001/XMLSchema#string

Sam Ogwang

http://www.w3.org/2001/XMLSchema#string

Susan Kayes

http://www.w3.org/2001/XMLSchema#string

Susan Nakubulwa

http://www.w3.org/2001/XMLSchema#string

P2860

Global incidence of multidrug-resistant tuberculosis

Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa

Ethionamide activation and sensitivity in multidrug-resistant Mycobacterium tuberculosis

Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology

M. tuberculosis genotypic diversity and drug susceptibility pattern in HIV-infected and non-HIV-infected patients in northern Tanzania.

Community based approaches to the control of multidrug resistant tuberculosis: introducing "DOTS-plus".

Determinants of drug-resistant tuberculosis: analysis of 11 countries.

Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs--worldwide, 2000-2004.

Mycobacterium tuberculosis growth at the cavity surface: a microenvironment with failed immunity

Predicting the outcome of therapy for pulmonary tuberculosis.

P304

1126-1134

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/592252

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P50

Edward Jones Lopez

Alison M Elliott

P577

2008-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23272500

http://www.w3.org/2001/XMLSchema#string

P698

18808360

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

P932

2883442

http://www.w3.org/2001/XMLSchema#string